What is the impact of PPAR-gamma agonist-rosiglitazone on ovarian reserve after hysterectomy? An experimental study

Gundogdu B., Tapisiz O. L., Dilbaz B., Mulazimoglu S. B., Muftuoglu K. H., Dundar B., ...Daha Fazla

TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.50, sa.5, ss.1399-1408, 2020 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 50 Sayı: 5
  • Basım Tarihi: 2020
  • Doi Numarası: 10.3906/sag-2002-117
  • Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.1399-1408
  • Anahtar Kelimeler: Hysterectomy, ovarian reserve, rat, Doppler ultrasonography, PPAR gamma, rosiglitazone, ANTI-MULLERIAN HORMONE, TOTAL ABDOMINAL HYSTERECTOMY, ESTROUS-CYCLE, PREMENOPAUSAL WOMEN, SERUM FSH, EXPRESSION, AGE
  • Ankara Üniversitesi Adresli: Evet

Özet

Background/aim: To evaluate the effects of hysterectomy on rat ovaries and the possible protective role of peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonist-rosiglitazone against ovarian reserve decrement.